said. Stepwise treatment to manage flare-ups depends on patient factors and asthma severity. ... Tice. “Are [the asthma biologics] affordable for patients? Really, they're not,” he said.
QD: News Every Day--Azithromycin may benefit non-eosinophilic severe asthma exacerbations. Azithromycin did not reduce the rate of severe exacerbations and lower respiratory tract infections in patients with severe asthma, ... But, azithromycin was
IM 2012: It might not be asthma. During a session on diagnostic challenges in allergies (see tomorrow's Internal Medicine 2012 News for more on that), allergist Raymond Slavin, MD, MACP, ... We see it more and more often and it is very often confused
QD: News Every Day--Gene variants in asthma diminish steroid inhaler's efficacy. ... Less than 4% of those who drank 1 to 6 units per week developed asthma.
What I learned from asthma. As a kid I had allergies and asthma. ... Asthma has played a minimal role in my adult life. Only occasionally do I use my albuterol inhaler before I run.
Conversely, the presence of asthma in a patient's history can also confound diagnosis. ... Making this particularly tricky, asthma is a risk factor for anaphylaxis and increases the risk of death from an allergic reaction, especially in teens.
In a study which included more than 900 Texas nurses, those who regularly cleaned medical instruments were 67% more likely to have newly diagnosed asthma and those who worked with solvents ... and glues were 51% more likely to report asthma symptoms.
We might question, for example, an assessment of the quality of asthma care based on hospitalization rates in the local population that did not take into account the fact that some ... communities have a much higher prevalence of asthma than other.
Like this one:. "Women and Tobacco: A lesson for mankind". Finally, there is an event called "Asthma Bingo" in the exhibit hall, with the prize being a free CPAP machine.
In 2007, an estimated 3.8 million children suffered an asthma attack or episode. ... Genome-wide association studies are also being employed to unravel the pharmacogenomics of asthma drug responsiveness.